Patent · US Active

Modified alginates for anti-fibrotic materials and applications

US10709818B2 · kind B2 · utility

1Cited by

14References

35Claims

0Family size

Assignees

Inventors

Arturo Jose Vegas · Belmont, US
Joshua C. Doloff · Quincy, US
Omid Veiseh · Bellaire, US
Minglin Ma · Ithaca, US
Robert S. Langer · Newton, US
Daniel Griffith Anderson · Framingham, US

Key dates

Filing date	Nov 2, 2016
Grant date	Jul 14, 2020
Priority date	—
Expiry date	Nov 9, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N5/0677
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for coating of any material where reduced fibrosis is desired, such as encapsulated cells for transplantation and medical devices implanted or used in the body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.